A comprehensive view of Capsules/Pills/Tablets. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Analysts on Enanta suing Pfizer over Covid pill Paxlovid: SVB Securities says it's unclear whether Enanta is in the right, noting patent dates might not prove who 'invented' technology first; RBC says it could take years for lawsuit to reach conclusion

Enanta files suit in US District Court against Pfizer seeking damages for copyright infringement related to Paxlovid nirmatrelvir, ritonavir tablets; Enanta applied for a patent for a coronavirus protease inhibitor in 2020 and received patent this month

Pet Releaf debuts supplement line to aid stress, joint, skin and digestive issues, available in hemp oils, capsules, chews and topical balm; company uses wind-powered baking facilities and hemp oil boxes made from 100% tree-free, biodegradable materials

Pfizer partners with MorphoSys, Incyte to evaluate combined therapy to treat diffuse large B-cell lymphoma, a type of blood cancer; drugs include Pfizer’s experimental TTI-622, Morphosys and Incyte’s Monjuvi tafasitamab-cxix, Revlimid lenalidomide

Scientific Industries releases redesigned VIVID automated pill counter designed to help pharmacists dispense medications safely, streamline their workflow; VIVID now counts most translucent pills, detects pill fragments, incorrect pills, foreign objects

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count